Medipharm Labs Australia enters sales, manufacturing agreement with producer
MediPharm Labs announced that its subsidiary MediPharm Labs Australia Pty has entered a private label sales and manufacturing agreement with a Licensed Producer in Australia. Under the terms of the manufacturing agreement with the Licensed Producer, MediPharm Labs Australia will purchase dried flower from the Licensed Producer and sell high quality, private-label cannabis oil and manufactured products. The agreement has a 12-month term with options to extend. MediPharm Labs Australia has also successfully negotiated multi-year supply agreements with three Australian Office of Drug Control approved cultivators. This input supply will support the extraction and production of private label oil in Australia for local and international markets.